Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 60 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-06 Ho Tony W Executive VP, Head of R&D Shares withheld for taxes −12,607 $69.17 $872K 52,364
2021-12-03 Ho Tony W Executive VP, Head of R&D Option exercise +26,667 64,971
2021-12-03 Ho Tony W Executive VP, Head of R&D Option exercise · Restricted Stock Units +26,667 13,333
2021-10-15 Ho Tony W Executive VP, Head of R&D Grant or award · Stock Option (Right to Buy) +13,800 13,800
2021-03-11 Ho Tony W Executive VP, Head of R&D Grant or award · Stock Option (Right to Buy) +23,334 23,334
2021-03-11 Ho Tony W Executive VP, Head of R&D Grant or award · Restricted Stock Units +9,000 9,000
2021-03-10 Ho Tony W Executive VP, Head of R&D Option exercise +4,583 40,445
2021-03-10 Ho Tony W Executive VP, Head of R&D Shares withheld for taxes −2,141 $124.15 $266K 38,304
2021-03-05 Ho Tony W Executive VP, Head of R&D Option exercise +3,333 37,447
2021-03-05 Ho Tony W Executive VP, Head of R&D Shares withheld for taxes −1,585 $114.65 $182K 35,862
2020-12-21 Ho Tony W Executive VP, Head of R&D Option exercise +23,551 $16.90 $398K 57,515
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −1,700 $148.11 $252K 55,815
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −900 $149.18 $134K 54,915
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −1,600 $150.16 $240K 53,315
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −1,100 $151.58 $167K 52,215
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −500 $152.41 $76K 51,715
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −1,400 $147.05 $206K 50,315
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −8,400 $148.38 $1.2M 41,915
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −5,000 $149.73 $749K 36,915
2020-12-21 Ho Tony W Executive VP, Head of R&D Sale −2,951 $150.61 $444K 33,964

Page 1 of 3 · 41 trades